Immuno-stromal axes regulate fibroblast heterogeneity in tissue fibrosis and regeneration
免疫基质轴调节组织纤维化和再生中成纤维细胞的异质性
基本信息
- 批准号:10879203
- 负责人:
- 金额:$ 24.9万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2022
- 资助国家:美国
- 起止时间:2022-05-01 至 2026-05-31
- 项目状态:未结题
- 来源:
- 关键词:
项目摘要
Project Summary
Tissue damage due to injury, disease, or congenital defect continues to be a critical clinical obstacle in
human health. Regenerative medicine-based therapies are a promising strategy, yet the critical determinants of
success are the immune response and fibrosis. Typically, in tissue repair, inflammation is closely controlled
before remodeling by activated fibroblasts, whose presence is also tightly regulated. Immunomodulation is a
promising strategy to avoid fibrotic outcomes, yet it is not the immune cells that directly participate in tissue
remodeling and collagen production. Therefore, it is critical to understand how immune cells coordinate stromal
cells to promote tissue repair or fibrosis. In fibrosis, evidence suggests that chronic immune cell infiltration and
proinflammatory cytokines accompany fibroblasts poised to promote fibrosis. Those fibroblasts are characterized
by aberrant mechanotransduction (i.e. sensing “normal”/soft as stiff/scarred) leading to the overproduction of
ECM. We now know that immune cells and fibroblasts exist as phenotypically distinct subpopulations, including
those with a molecular signature tied to fibrosis. Whether inflammatory signals elicit distinct fibroblast
subpopulations with aberrant mechanotransduction in fibrosis is unknown and is a key objective. Understanding
the relationship between inflammation and fibroblast heterogeneity is essential to predict the regenerative
potential of therapies. I hypothesize that fibroblast subpopulations exist during fibrosis with aberrant
mechanotransduction that is regulated by inflammatory signaling. During the mentored K99 phase of this
application, I will identify the immune and fibroblast subpopulations that emerge during tissue regeneration and
fibrosis leveraging non-fibrotic/regenerative microporous annealed particle hydrogels (MAP gels) and fibrotic
nonporous bulk hydrogels (NP gels). I will determine the mechanotransductive differences across those
subpopulations by purifying them with identified markers and measuring ECM production, myofibroblastic
differentiation, integrin activation, and focal adhesion signaling. I will identify signaling pathways necessary for
the phenotypes unique to fibroblast subpopulations. I will validate these findings by confirming the identified
fibroblast subpopulations and signaling pathways in fibrotic clinical implants. I will continue my scientific and
professional development in preparation for the independent phase with consistent guidance from my scientific
advisory committee, diversity advisory committee, and collaborators. During the independent phase, I will
determine mediators unique to regenerative and fibrotic microenvironments using MAP and NP gels. I determine
if IL-1 signaling in fibroblasts is necessary for fibrosis by implanting NP gels in fibroblast-specific IL-1RI knockout
mice. I will also determine whether IL-1 signaling is sufficient to promote fibrosis using MAP gels conjugated with
IL-1?. We pose an innovative hypothesis that seeks to bridge the gap between inflammation and disrupted
mechanotransduction distinctive of fibrotic disorders. This proposal will equip me with scientific and professional
training that will enable me to launch a successful and diverse research program as an independent investigator.
项目摘要
由于损伤、疾病或先天性缺陷引起的组织损伤仍然是治疗糖尿病的关键临床障碍。
人体健康基于再生医学的疗法是一种很有前途的策略,然而,
免疫反应和纤维化。通常,在组织修复中,炎症受到严格控制,
然后由活化的成纤维细胞重塑,其存在也受到严格调控。免疫调节是一种
有希望的策略,以避免纤维化的结果,但它不是免疫细胞直接参与组织
重塑和胶原蛋白生成。因此,了解免疫细胞如何协调基质细胞是至关重要的。
细胞以促进组织修复或纤维化。在纤维化中,有证据表明慢性免疫细胞浸润和
促炎性细胞因子伴随着成纤维细胞准备促进纤维化。这些成纤维细胞的特征是
通过异常的机械传导(即感觉“正常”/软如硬/疤痕)导致过度生产
ECM。我们现在知道,免疫细胞和成纤维细胞作为表型不同的亚群存在,包括
那些与纤维化有关的分子特征。炎症信号是否引起不同的成纤维细胞
纤维化中具有异常机械转导的亚群是未知的,并且是关键目标。理解
炎症和成纤维细胞异质性之间的关系对于预测再生性纤维化是至关重要的。
治疗的潜力。我假设纤维化过程中存在成纤维细胞亚群,
机械传导受炎症信号调节。在K99阶段,
应用,我将确定免疫和成纤维细胞亚群出现在组织再生,
纤维化利用非纤维化/再生微孔退火颗粒水凝胶(MAP凝胶)和纤维化
无孔本体水凝胶(NP凝胶)。我将确定这些细胞之间的机械传导差异,
通过用鉴定的标记物纯化它们并测量ECM产生、肌纤维母细胞
分化、整合素活化和粘着斑信号传导。我将识别出
成纤维细胞亚群特有的表型。我将通过确认已确定的
纤维化临床植入物中的成纤维细胞亚群和信号通路。我将继续我的科学和
专业发展,为独立阶段做准备,并在我的科学指导下,
咨询委员会,多样性咨询委员会和合作者。在独立阶段,我将
使用MAP和NP凝胶确定再生和纤维化微环境特有的介质。I determine
如果通过在成纤维细胞特异性IL-1 RI敲除中植入NP凝胶,
小鼠我还将使用偶联有以下的MAP凝胶来确定IL-1信号传导是否足以促进纤维化:
IL-1?我们提出了一个创新的假设,试图弥合炎症和破坏之间的差距。
纤维化疾病的机械传导特征。这一建议将使我具备科学和专业的
培训,这将使我能够启动一个成功的和多样化的研究计划,作为一个独立的调查员。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Daniel Abebayehu其他文献
Daniel Abebayehu的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Daniel Abebayehu', 18)}}的其他基金
Immuno-stromal axes regulate fibroblast heterogeneity in tissue fibrosis and regeneration
免疫基质轴调节组织纤维化和再生中成纤维细胞的异质性
- 批准号:
10428972 - 财政年份:2022
- 资助金额:
$ 24.9万 - 项目类别:
Inflammatory Cytokines Promotes Pro-Fibrotic Thy-1 Negative Fibroblast Subpopulations In Lung Fibrosis
炎症细胞因子促进肺纤维化中促纤维化 Thy-1 阴性成纤维细胞亚群
- 批准号:
10166770 - 财政年份:2019
- 资助金额:
$ 24.9万 - 项目类别:
Inflammatory Cytokines Promotes Pro-Fibrotic Thy-1 Negative Fibroblast Subpopulations In Lung Fibrosis
炎症细胞因子促进肺纤维化中促纤维化 Thy-1 阴性成纤维细胞亚群
- 批准号:
9759526 - 财政年份:2019
- 资助金额:
$ 24.9万 - 项目类别:
相似国自然基金
HIF-1α和SDF-1α/CXCR4在调控神经元前体细胞迁移中的作用研究
- 批准号:30800319
- 批准年份:2008
- 资助金额:18.0 万元
- 项目类别:青年科学基金项目
缺血条件下SDF-1/CXCR4轴调控心脏干细胞归巢研究
- 批准号:30800480
- 批准年份:2008
- 资助金额:19.0 万元
- 项目类别:青年科学基金项目
胸腺基质淋巴生成素在乳腺癌患者调节性T细胞分化和Th细胞极化中的作用
- 批准号:30872986
- 批准年份:2008
- 资助金额:30.0 万元
- 项目类别:面上项目
相似海外基金
Investigating bioengineering approaches to produce immuno-modulatory mesenchymal stromal cells and their extracellular vesicle
研究生产免疫调节间充质基质细胞及其细胞外囊泡的生物工程方法
- 批准号:
2608627 - 财政年份:2025
- 资助金额:
$ 24.9万 - 项目类别:
Studentship
Developing functionalised electrospun scaffolds to exploit neural stromal interactions in wound healing
开发功能化电纺支架以利用神经基质相互作用促进伤口愈合
- 批准号:
2910663 - 财政年份:2024
- 资助金额:
$ 24.9万 - 项目类别:
Studentship
Role of Natural Antibodies and B1 cells in Fibroproliferative Lung Disease
天然抗体和 B1 细胞在纤维增生性肺病中的作用
- 批准号:
10752129 - 财政年份:2024
- 资助金额:
$ 24.9万 - 项目类别:
Glut1+ cancer associated fibroblasts enforce a metabolic barrier to tumor T cell infiltration
Glut1癌症相关成纤维细胞增强了肿瘤T细胞浸润的代谢屏障
- 批准号:
10752508 - 财政年份:2024
- 资助金额:
$ 24.9万 - 项目类别:
早期膵癌におけるstromal-epithelial interactionの分子制御機構の解明
阐明早期胰腺癌基质-上皮相互作用的分子控制机制
- 批准号:
24K11123 - 财政年份:2024
- 资助金额:
$ 24.9万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
A human tissue-engineered three-layer cornea (hTEC) supplemented with macrophages as a biomaterial for in vitro studies
补充有巨噬细胞的人体组织工程三层角膜(hTEC)作为体外研究的生物材料
- 批准号:
488980 - 财政年份:2023
- 资助金额:
$ 24.9万 - 项目类别:
Operating Grants
Establishment of therapeutic strategy for corneal stromal scaring treatment by applying the ZFP521 gene.
应用ZFP521基因建立角膜基质疤痕治疗策略。
- 批准号:
23K09045 - 财政年份:2023
- 资助金额:
$ 24.9万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
A study on division of photosynthetic metabolism associated with the uneven distribution of Rubisco and starch in the chloroplast stromal space
叶绿体基质空间中Rubisco和淀粉分布不均与光合代谢划分的研究
- 批准号:
23H02195 - 财政年份:2023
- 资助金额:
$ 24.9万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
REGULATION OF BONE MARROW MESENCHYMAL STEM CELLS BY VCAM1
VCAM1 对骨髓间充质干细胞的调节
- 批准号:
10537391 - 财政年份:2023
- 资助金额:
$ 24.9万 - 项目类别:
Bioorthogonal probe development for highly parallel in vivo imaging
用于高度并行体内成像的生物正交探针开发
- 批准号:
10596786 - 财政年份:2023
- 资助金额:
$ 24.9万 - 项目类别: